PSI Aktiengesellschaft fuer Produkte und Systeme der Informationstechnologie is a Germany-based company that develops and integrates software for energy suppliers, manufacturers and infrastructure operators. It operates through three segments. The Energy Management segment serves utility companies in the electricity, gas, oil, water, district heating and combined energy sectors, and focuses on solutions for grid management, energy storage, energy trading and virtual power plants. The Production Management segment provides software for production planning, production control and logistics for the metal industry, machinery and plant engineering, the automotive industry and logistics. The Infrastructure Management segment develops control system software for the operation of infrastructure in the areas of rail and road transport and public safety with focus on operation-control technology, depot management and safety and telematics applications.

Company Growth (employees)
Berlin, DE
Size (employees)
1,626 (est)-1%
PSI was founded in 1969 and is headquartered in Berlin, DE

PSI Office Locations

PSI has an office in Berlin
Berlin, DE (HQ)
42 Dircksenstraße

PSI Data and Metrics

PSI Financial Metrics


Market capitalization (22-Sep-2017)

270.3 m

Closing share price (22-Sep-2017)

PSI's current market capitalization is €270.3 m.
Show all financial metrics

PSI Market Value History

Traffic Overview of PSI

PSI Online and Social Media Presence

PSI News and Updates

How psychedelics like psilocybin and LSD actually change the way people see the world

Psychedelic substances like LSD and psilocybin — the active ingredient in magic mushrooms — are powerful, able to transform the way that people who use them perceive the world. Because of that, after years of prohibition, psychiatric researchers in the US are hoping to take…

What it’s like to take the hallucinogenic psilocybin as medicine

For the researchers that are trying to see if hallucinogenic substances like psilocybin, the active ingredient in magic mushrooms, can be used safely as medicine, it's essential to make sure that patients are prepared to have a safe experience. After all, the resurgent curr…

Magic mushroom ingredient psilocybin can lift depression, studies show

Immediate reduction in depression and anxiety for up to eight months seen in patients with advanced cancer given a single dose of psilocybinA single dose of psilocybin, the active ingredient of magic mushrooms, can lift the anxiety and depression experienced by people with advanced cancer for six mo…

BRIEF-pSivida reports positive results from investigator-sponsored phase 2 study of Medidur

* Results from investigator-sponsored phase 2 study of Medidur showed no recurrence of uveitis in 11 eyes treated with Medidur in 2 years after implant Source text for Eikon: Further company coverage:

PSI Company Life and Culture

You may also be interested in